Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00453
|
|||||
| Drug Name |
Oxcarbazepine
|
|||||
| Synonyms |
10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide; 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide; Desitin brand of oxcarbazepine; Epilexter; Epliga; GP 47680; GP-47680; KIN-493; Novartis brand of oxcarbazepine; O0363; Oxacarbazepine; Oxaleptal (TN); Oxcarbamazepine; Oxcarbazepime; Oxcarbazepina; Oxcarbazepina [INN-Spanish]; Oxcarbazepine (USAN/INN); Oxcarbazepine [INN]; Oxcarbazepinum; Oxcarbazepinum [INN-Latin]; SPN-804; Timox; Trileptal; Trileptal (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Epilepsy [ICD11: 8A6Z] | Approved | [1] | |||
| Therapeutic Class |
Anticonvulsants
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H12N2O2
|
|||||
| Canonical SMILES |
C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
|
|||||
| InChI |
InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)
|
|||||
| InChIKey |
CTRLABGOLIVAIY-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 28721-07-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 252.27 | Topological Polar Surface Area | 63.4 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
1.7
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103292787
, 11364569
, 11367131
, 11369693
, 11372776
, 11374387
, 11377855
, 11484081
, 11488299
, 11491484
, 11492449
, 11495489
, 11528646
, 12013820
, 15196775
, 24724563
, 26612687
, 26679796
, 26719673
, 26747194
, 26747195
, 34676003
, 46386767
, 46507580
, 47291388
, 47365462
, 50085868
, 50105170
, 53790510
, 57311661
, 75522661
, 7784956
, 7847599
, 7980216
, 81040908
, 81093135
, 8173559
, 866068
, 866523
, 87561105
, 92124721
, 92307920
, 92308514
, 92309109
, 92711414
, 93166236
, 96099912
, 9695
, 99233256
, 99437127
|
|||||
| ChEBI ID |
CHEBI:7824
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Oxcarbazepine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | The transport of antiepileptic drugs by P-glycoprotein. Adv Drug Deliv Rev. 2012 Jul;64(10):930-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.